Skip to main content

Table 5 Antitumor Effects

From: Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients

  < 70 Years (n = 14) ≥ 70 Years (n = 8) P values*
RR (%) 60.0 50.0 0.5490
DCR (%) 100 83.3 0.3750
CR/PR/SD/PD/NE 0/6/4/0/2 0/3/2/1/1 -
  1. Abbreviation: CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; NE, not evaluable; RR, response rate (CR+PR); DCR, disease control rate (CR+PR+SD).
  2. *P values were calculated with the use of Fisher's exact probability test.